-
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by Analysts
Source: Buzz FX / 03 Feb 2025 05:31:08 America/Chicago
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by Analysts Written by MarketBeat February 3, 2025 Share Link copied to clipboard. Shares of LENZ Therapeutics, Inc. ( NASDAQ:LENZ - Get Free Report ) have earned a consens
Read more...